A detailed history of Hfm Investment Advisors, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Hfm Investment Advisors, LLC holds 3 shares of EXAS stock, worth $201. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3
Previous 5 40.0%
Holding current value
$201
Previous $266,000 38.35%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$40.91 - $56.0 $81 - $112
-2 Reduced 40.0%
3 $164,000
Q2 2025

Jul 22, 2025

BUY
$40.31 - $58.08 $161 - $232
4 Added 400.0%
5 $266,000
Q1 2025

May 16, 2025

BUY
$43.04 - $58.51 $43 - $58
1 New
1 $44,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Hfm Investment Advisors, LLC Portfolio

Follow Hfm Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hfm Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hfm Investment Advisors, LLC with notifications on news.